We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Patent Office Review Board Strikes Down Genzyme’s Biologics Therapy Patents
Patent Office Review Board Strikes Down Genzyme’s Biologics Therapy Patents
A U.S. patent office review board has struck three of Sanofi subsidiary Genzyme’s patents in what appears to be the first time such a review has nixed a biologics patent.